The Significance Of The Polymorphic Marker Aluins / Dell> D Of The Ace Gene In The Development Of Diabetic Nephropathy
DOI:
https://doi.org/10.62480/tjms.2022.vol5.pp7-10Keywords:
diabetic nephropath, diabetes mellitus, gene, polymorphismAbstract
This article presents the results of a study of 129 patients with type 2 diabetes and 110 healthy people to determine whether the polymorphic markers AluIns / Dell> D of the ACE gene are associated with the development of diabetic nephropathy (DN). Patients in the main group: 65 patients with a disease duration of up to 10 years, without diabetic nephropathy (33 patients) and with diabetic nephropathy (32 patients), 64 patients with diabetes lasting more than 10-20 years, with no diabetic nephropathy (31 patients ) and diabetic nephropathy (33 patients). Genotyping was carried out using the polymerase chain reaction method. The study showed that the association of the D allele and the heterozygous I/D genotype of the ACE gene play a role in the development of diabetic nephropathy in patients with type 2 diabetes mellitus in the studied Uzbek nation.
References
Dedov I.I., Shestakova M.V., ed. Complications of diabetes mellitus. Treatment and prevention. M .: MIA; 2017.83 p.
Dedov I.I., Shestakova M.V., ed. Diabetes. Acute and chronic complications. M.: MIA; 2011.197p.
Jeleznyakova AV, Lebedeva NO, Vikulova OK, et al. The risk of developing chronic kidney disease in patients with type 2 diabetes is determined by polymorphism of the NOS3, APOB, KCNJ11, TCF7L2 genes // Diabetes mellitus. 2014. No. 3. PP. 23-30.
Jabborov O.O. Genetic factors of diabetic nephropatia in patients with type 2 diabetes mellitus // Global journal of medical research. No.1, 2019. PP. 1-7
Jabborov O.O. Features of Genetic polymorphism in population with diabetic nephropathia: Literature review // Journal of advances in medicine and medical research No. 29(9), 2019: PP. 1-7.
Jabbarov O.O. Significance of the RAAS coding component of the ACE gene in the development of diabetic nephropathy in type 2 diabetes // Infection, immunity and pharmacology. No.6, 2019. PP. 47-55
Ezzidi I., Mtiraoui N., Kacem M. et.al. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy // Diabetes / Metabolism Research and Reviews. 2009. Vol. 25, no.8. P. 717-724.
Morshed M., Khan H., Akhteruzzaman S. Association between angiotensin I-converting enzyme gene polymorphism and hypertension in selected individuals in the Bangladeshi population // Journal of Biochemistry and Molecular Biology. 2002. Vol. 35, no. 3. P. 251-254.
Settin A., Elbaz R., Abbas A., et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Egyptian patients with myocardial infarction // Journal of the Renin-Angiotensin-Aldosterone System. 2009. No. 10. R. 96-100.
Sauca O.E., Carpini S.D., Zagato L., et.al. Role of angiotensin-converting enzyme insertion / deletion polymorphism in type 1 diabetes nephropathy. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2012. Vol. 19, no. 2. P. 143-149.
Shanmuganathan R., Kumaresan R., Giri P. Prevalence of angiotensin converting enzyme (ACE) gene insertion / deletion polymorphism in South Indian population with hypertension and chronic kidney disease // Journal of Postgraduate Medicine. 2015. Vol. 61, no. 4. P. 230-234.
Uddin M., Azam M., Chowdhury N., et al. Angiotensin I-Converting Enzyme Gene Polymorphism in Type 2 Diabetic Patients with Nephropathy // Journal of Medical Sciences. 2007. No. 7. P. 682-685.
Yu Z.Y., Chen L.S., Zhang L.C., et. al. Metaanalysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy // Nephrology. 2012. Vol. 17, no. 5. P. 480.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
